✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Marksans Pharma Ltd.

MARKSANS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹7,552 Cr.
P/E
21.57

Marksans Pharma Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
7,552 Cr
PE
PE
21.57
Prom Holding
Prom Holding
43.87 %
ROE (%)
ROE (%)
15.43
ROCE (%)
ROCE (%)
18.67
Div Yield (%)
Div Yield (%)
0.48
Sales
Sales
2,652 Cr
OPM (%)
OPM (%)
18.86 %
Debt to Equity
Debt to Equity
0.01
View more
Edit Ratio's
About
Marksans Pharma is an Indian pharmaceutical company with a global presence, excelling in resea… Read more
Low
163
52W Range
High
359
  • Marksans Pharma
  • Strides Pharma Scien
  • FDC
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

10 Yes

Positive for this company

3 Neutral

Neutral for this company

3 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Segment

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Marksans Pharma Ltd. Business

    Marksans Pharma is an Indian pharmaceutical company with a global presence, excelling in research, manufacturing, and marketing of finished dosage pharmaceutical formulations. Their focus areas include a wide range of OTC & prescription drugs across various fields.

    Marksans Pharma major competitors are Strides Pharma Scien, FDC, Sequent Scientific, Procter&Gamble Healt, Guj. Themis Biosyn, Zota Health Care, Sanofi India.
    Market Cap of Marksans Pharma is ₹7,552 Crs.
    While the median market cap of its peers are ₹7,434 Crs.

    Marksans Pharma seems to be less financially stable compared to its competitors.
    Altman Z score of Marksans Pharma is 8.74 and is ranked 4 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    Discussions & Analysis
    Marksans Pharma Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material